Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Non-Current Deferred Tax Liability (2021 - 2025)

Zymeworks' Non-Current Deferred Tax Liability history spans 5 years, with the latest figure at $6.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 35.91% to $6.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.0 million, a 35.91% decrease, with the full-year FY2025 number at $6.0 million, down 35.91% from a year prior.
  • Non-Current Deferred Tax Liability hit $6.0 million in Q4 2025 for Zymeworks, up from $4.8 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for ZYME hit a ceiling of $14.1 million in Q4 2021 and a floor of $1.6 million in Q3 2022.
  • Historically, Non-Current Deferred Tax Liability has averaged $5.2 million across 5 years, with a median of $3.5 million in 2024.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: plummeted 75.14% in 2023 and later skyrocketed 185.03% in 2024.
  • Tracing ZYME's Non-Current Deferred Tax Liability over 5 years: stood at $14.1 million in 2021, then fell by 5.89% to $13.3 million in 2022, then plummeted by 75.14% to $3.3 million in 2023, then soared by 185.03% to $9.4 million in 2024, then tumbled by 35.91% to $6.0 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for ZYME at $6.0 million in Q4 2025, $4.8 million in Q3 2025, and $4.8 million in Q2 2025.